University of Nebraska Wins the Abbott and Big Ten Conference’s Nationwide…
Nearly 20,000 Big Ten students, alumni and fans across the country donated blood as part of the Abbott-Big Ten…
Author
25275 posts
Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Shows High…
Data presented at the 66th Annual Meeting and Exposition of the American Society of Hematology (ASH)NORTH CHICAGO,…
Syndax Presents Positive Revuforj® (revumenib) Data in Acute Leukemias from…
– 82% ORR (27 of 33 pts) and 48% CR/CRh (16 of 33 pts) in SAVE trial studying revumenib in combination with…
New Data from PROMMIS Study Highlights the Power of SKY92 in Identifying High-Risk…
ROTTERDAM, the Netherlands and SAN DIEGO, Dec. 7, 2024 /PRNewswire/ -- SkylineDx, an innovative diagnostics company…
Media Advisory -Prime Minister’s itinerary for Sunday, December 8, 2024
OTTAWA, ON, Dec. 7, 2024 /CNW/ - National Capital Region, Canada
No public events scheduled
This document is also…
MosquitoMate receives first Vector Expedited Review Voucher (VERV) from the US…
LEXINGTON, Ky., Dec. 7, 2024 /PRNewswire/ -- The US Environmental Protection Agency (EPA) has just announced…
Building Homes for Heroes Gifts 400th Home, Marking Historic Achievement in…
Building Homes for Heroes & Hillwood Properties partner to gift milestone home in Dallas, Texas
NEW YORK, Dec.…
Updated Results of Phase 3 ALLELE Study Presented at 66th American Society of…
Tabelecleucel treated relapsed or refractory EBV+ PTLD patients achieved a 50.7% Objective Response Rate (ORR),…
Blueprint Medicines’ Continued Leadership in Redefining the Standard of Care…
-- ASH data reinforce survival benefits of front-line AYVAKIT® (avapritinib) use in patients with advanced SM --
--…
Nektar Therapeutics Announces NKTR-255 Following CD19-directed CAR-T Therapy…
73% of the NKTR-255 treatment group compared to 50% of the placebo group achieved a complete response at 6 months…
Ethara: THE ART OF CURATING THE ABU DHABI GRAND PRIX HOSPITALITY EXPERIENCE
ABU DHABI, UAE, Dec. 7, 2024 /PRNewswire/ -- The tens of thousands of visitors at this week's Abu Dhabi Grand Prix…
Phase 2 data from the ongoing HIBISCUS study shows promise that investigational…
Data indicated a trend toward reduced incidence of vaso-occlusive crises over 52 weeks and increased hemoglobin…
Researchers Report New Opportunities to Improve Quality of Life for People with…
Studies show promising new options to address unmet needs in sickle cell disease and immune thrombocytopenia
SAN…
Blokees’ Figures from Multiple IPs Amaze Fans at 2024 Singapore Comic Con
SHANGHAI, Dec. 7, 2024 /PRNewswire/ -- During the two-day 2024 Singapore Comic Con (December 7–8), Blokees unveiled…
New Research from Children’s Hospital of Philadelphia to Transform Standard…
Results will be presented at the 66th American Society of Hematology Annual Meeting
PHILADELPHIA, Dec. 7, 2024…
Research Shows How Lifestyle Factors and Diet Affect Hematologic Care
Studies highlight interactions among lifestyle factors, disease development, and response to treatment
SAN DIEGO,…
WOLF INVESTOR DEADLINE: Wolfspeed, Inc. Investors with Substantial Losses Have…
SAN DIEGO, Dec. 7, 2024 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that…
Seattle Children’s researchers greatly improve survival for children…
The findings will be presented during a scientific session at the American Society of Hematology Annual Meeting on…